Source: StreetInsider

Press Release: DePuy Synthes : DePuy Synthes Receives FDA Clearance for TELIGEN System

New MedTech Advancement Brings First-of-Its-Kind Technology to Spine Surgeons, Delivering Advanced Visualization and User-Centric Procedural Control RAYNHAM, Mass., Oct. 20,...

Read full article »
Est. Annual Revenue
$5.0-10B
Est. Employees
10-50K
CEO Avatar

General Manager

Colin Ward

CEO Approval Rating

74/100

Read more